Last Updated: January 2026 | Verified for 2026 AMA, CPT & CMS Guidelines
.
of the number of nerves/muscles tested, so accuracy in counting “studies” and documenting targets is essential .
. Use -25 on E/M when a separately identifiable visit occurs the same day, and use
-59 (or the more specific subset modifier) only when you must indicate a truly distinct diagnostic service beyond an edit .
This article clarifies a persistent real-world confusion: some clinicians and billing teams informally refer to “95938” when they mean a comprehensive electrodiagnostic evaluation (needle EMG plus extensive nerve conduction studies). However, under the AMA CPT code descriptor, CPT 95938 is an evoked potential (SSEP) procedure, not an EMG/NCS code . If your goal is to bill a same-day EMG with multiple NCS, the compliant path is to code the NCS with one code from 95907–95913 based on the total number of studies and then add the appropriate EMG add-on code(s) 95885–95887 when needle EMG is performed on the same date
.
Because electrodiagnostic testing is heavily policy-driven, this guide focuses on what payers and auditors typically look for: clear medical necessity, accurate study counts, correct use of add-on structure, and correct component billing. Coverage and documentation expectations are described in both Medicare guidance and major payer medical policies .
The authoritative CPT descriptor for 95938 describes a bilateral SSEP study of upper and lower limbs
. SSEPs are neurophysiologic tests measuring conduction along sensory pathways from peripheral
nerves through the spinal cord to cortical responses. They are commonly used in certain neurologic evaluations and can be used in intraoperative contexts, depending on the monitoring configuration and coding rules in effect for the service being provided.
Why the confusion exists: many comprehensive EMG/NCS evaluations in complex neuropathy or radiculopathy workups do involve testing multiple limbs and multiple nerves and muscles. This “four-limb comprehensive study” concept can resemble the “upper and lower limbs, bilateral” wording people see attached to 95938. However, the test modality is different. EMG/NCS are electrodiagnostic studies focused on muscle electrical activity (needle EMG) and peripheral nerve conduction (NCS), whereas 95938 is an evoked potential pathway study
.
Compliance risk: Billing 95938 to represent EMG/NCS services can create a mismatch between the billed CPT descriptor and the test actually performed. If an auditor compares the report to the descriptor, the claim can be denied or recouped. The safer approach is to bill EMG/NCS with the correct EMG add-on code(s) plus the single correct NCS code based on study count, and reserve 95938 for the SSEP procedure described by CPT .
Most payer policies and Medicare guidance describe EMG/NCS in a structured way: you select exactly one NCS code from 95907–95913 per patient per day (based on the total number of studies performed that day) and you add the EMG add-on code(s) 95885 (limited) or 95886 (complete) per extremity when needle EMG is performed in conjunction with NCS on that date.
The 95907–95913 family is chosen by the number of studies performed. Medicare guidance and payer policies emphasize that the study count is not simply “number of nerves,” but rather the number of discrete conduction tests, which may include sensory and motor evaluations and certain late responses when performed and counted under the policy framework.
In practice, coders should use the same counting method consistently and ensure the report structure makes the count transparent.
Key billing concept: report only one NCS code per day (for example, 95909 for 5–6 studies or 95911 for 9–10 studies). Payer policies treat these as a single “bucket” code representing the day’s NCS volume .
When NCS are performed on the same date as needle EMG, AMA/CPT coding structure (as reflected in billing education and Medicare guidance) requires using the add-on EMG codes rather than the older standalone extremity EMG codes
.
.
.
Many payer policies explicitly define indications and limitations for EMG/NCS and expect that the needle EMG component is not superficial.
For example, policies describing EMG/NCS medical necessity often highlight that NCS without needle EMG may provide incomplete information for many diagnostic questions, reinforcing that combined testing should be clinically purposeful and documented .
Documentation is the primary determinant of whether electrodiagnostic claims survive audit. Medicare billing guidance and major payer medical policies consistently emphasize complete reporting: what was tested, how it was tested, quantitative values, and an interpretive impression tied to the clinical question .
A report format that routinely performs well in reviews is a two-part structure:
In addition, the AANEM recommended policy provides utilization expectations and emphasizes appropriate study design and documentation in the context of clinical indications and repeat testing .
Electrodiagnostic procedures are frequently billed as either global services (one entity provides equipment and interpretation) or split services (technical billed by the facility; professional billed by the interpreting physician). Medicare billing guidance commonly addresses the component billing framework and supervision expectations for diagnostic tests
.
An E/M service may be billed the same day as EMG/NCS when it is separately identifiable and not merely the pre-test assessment.
Payer medical policies commonly require clear documentation of distinct history/exam/decision-making separate from the procedure note . In that case, append -25 to the E/M code. Without clear separation, the E/M is vulnerable to denial or downcoding.
The CMS NCCI manual describes when modifier 59 (or a subset modifier) may be used to identify a distinct diagnostic procedure that is otherwise bundled under an edit, and it warns against routine modifier use without a true distinct-service rationale .
For EMG/NCS, the standard pairing of one NCS code plus appropriate EMG add-on code(s) is usually payable without modifier 59. Modifier 59 becomes relevant only in unusual circumstances (separate session, different anatomic site where policy requires distinction, or documented independent
diagnostic service beyond what an edit assumes).
Coverage is diagnosis- and context-dependent. Major payer policies and Medicare articles describe covered indications and limitations for EMG/NCS, and they typically emphasize that the test should answer a specific diagnostic question and influence management .
.
.
Payers often deny EMG/NCS for nonspecific complaints (diffuse pain without neurologic findings, routine screening) and may require clear clinical deficits or failure of conservative therapy for certain entrapment syndromes .
For repeat studies, professional recommendations and Medicare contractor approaches commonly expect a documented change in clinical status or a specific management question (pre-surgery reassessment, disease progression monitoring, new distribution of symptoms) .
Clinical: Right hand numbness with positive provocative testing.
Testing: NCS totals 3–4 studies; needle EMG of right upper extremity includes ≥5 muscles.
Coding approach: One NCS code for the day (e.g., 95908 if 3–4 studies) plus 95886 (complete extremity EMG) for the right arm.
Documentation focus: include median motor and sensory values (latency/amplitude) and EMG findings in median-innervated muscles,
then correlate to “median mononeuropathy at the wrist” impression.
Policy alignment: Typical covered indication and reporting expectations appear in Medicare guidance and payer medical policy
.
Clinical: Long-standing diabetes with distal sensory loss and gait imbalance.
Testing: NCS totals 9–10 studies; EMG includes complete exams in multiple extremities.
Coding approach: One NCS code matching count (e.g., 95911 for 9–10 studies) plus 95886 per extremity examined (up to four units).
If a separately identifiable new-patient evaluation occurs the same day, bill an E/M code with modifier -25.
Documentation focus: for -25, clearly separate the E/M note (history/exam/assessment/plan) from the procedure report.
For the test, present NCS/EMG tables and an impression consistent with length-dependent polyneuropathy.
Utilization notes: repeat testing should be justified if performed frequently; AANEM recommendations discuss reasonable repeat patterns .
Clinical: Neck pain with dermatomal symptoms and weakness suggesting C7 involvement.
Testing: NCS 5–6 studies; EMG of right upper extremity includes ≥5 muscles and includes related cervical paraspinals.
Coding approach: One NCS code (e.g., 95909 for 5–6 studies) plus 95886 for the right upper extremity.
Do not separately bill paraspinal EMG if it is included as “related paraspinal areas when performed” within the extremity EMG service structure.
Rules support: Medicare documentation and policy and payer coverage expectations describe this typical combined testing pattern
.
Clinical: Post-surgical patient returns with new or worsened symptoms eight months after a prior EMG/NCS.
Coding approach: Code the repeat study the same way as the initial (correct NCS bucket code + appropriate EMG add-ons). Typically no special modifier is required solely because it is a repeat on a different date, but the record should explicitly justify why repeat testing changes management (recurrence, new distribution, pre-op planning, progression).
Coverage reality: repeat frequency expectations are addressed in professional recommendations and are often reflected in payer review behavior .
| CPT Code | 2026 Descriptor Summary | How It’s Used in Practice |
|---|---|---|
| 95885 | Needle EMG, each extremity, with related paraspinal areas when performed, done with NCS; limited (add-on) | Use when an extremity EMG is performed with NCS on the same date and the extremity exam is limited in scope. |
| Commonly taught threshold is ≤4 muscles in the limb; always ensure the report lists each muscle tested | ||
| . | ||
| 95886 | Needle EMG, each extremity, with related paraspinal areas when performed, done with NCS; complete (add-on) | Use when the extremity EMG is complete, commonly framed as ≥5 muscles with appropriate breadth of innervation/levels. |
| Often used per limb in neuropathy/radiculopathy workups . | ||
| 95887 | Needle EMG, non-extremity muscles, done with NCS (add-on) | Use for specific non-extremity muscle testing with NCS when appropriate and not already included in the extremity EMG service structure. |
| Documentation must clearly identify muscles and purpose . | ||
| 95907–95913 | Nerve conduction studies “bucket” codes by number of studies performed | Select exactly one code per date of service based on total studies performed. Report structure should make the count transparent. |
| Medicare and payer policies often scrutinize study counts for reasonableness by indication . | ||
| 95937 | Neuromuscular junction testing (repetitive stimulation), each nerve | Specialized testing (e.g., suspected myasthenia). If billed, the report should document protocol and abnormal decrement/increment. |
| Policy expectations appear in Medicare guidance and payer medical policy . | ||
| 95938 | Short-latency somatosensory evoked potentials (SSEP), upper and lower limbs, bilateral | Use for the SSEP procedure described in CPT. Do not substitute this code for EMG/NCS; EMG/NCS should be coded with 95907–95913 plus 95885–95887 as applicable . |
Bottom line: if your clinical service is “EMG plus multiple NCS,” code it as an NCS bucket code (95907–95913) plus the correct EMG add-on code(s) (95885–95887). Reserve 95938 for the evoked potential SSEP procedure defined by CPT. This alignment between the performed test and the billed descriptor
is the foundation for passing payer edits and post-payment reviews.
© Copyright 2026 American Medical Association. All rights reserved.
Short-latency somatosensory evoked potential (SEP) studies are diagnostic tests that measure the electrical activity in the brain in response to sensory stimuli applied to peripheral nerves or skin sites. These studies are crucial for assessing the integrity of the somatosensory pathways, which are responsible for transmitting sensory information from the body to the central nervous system. The term "short-latency" refers to the rapid response time of the evoked potentials, which is categorized based on the latency of the waveform generated following stimulation. Specifically, short-latency SEPs are characterized by their quick onset, with the upper extremity nerves producing responses within 25 milliseconds and the tibial nerve responses occurring within 50 milliseconds after stimulation. Abnormal results from these tests can indicate dysfunction within the somatosensory pathways, which may be indicative of various neurological conditions. The procedure involves the application of electrical stimulation to the selected nerves, with electrodes strategically placed to capture the resulting electrical signals. This process allows for the detailed analysis of the neural pathways involved in sensory perception, providing valuable information for diagnosis and treatment planning.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.